DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

GlaxoSmithKline (NYSE: GSK)

41.25 0.04 (0.10%)

REAL-TIME: Last trade at

Extended Hours: $41.25 $0.00 (0.00%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

GSK $41.25 0.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.56
Previous Close $41.21
Daily Range $40.56 - $41.28
52-Week Range $39.27 - $49.24
Market Cap $89.6B
P/E Ratio 14.16
Dividend (Yield) $2.37 (6.0%)
Ex-Dividend Date
Dividend Pay Date
08/12/15
10/01/15
Volume 2,738,493
Average Daily Volume 4,017,942
Current FY EPS $2.44

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

GlaxoSmithKline Lines Its Pockets Courtesy of Novartis Once Again

GlaxoSmithKline and Novartis get together for another potential blockbuster deal.

Chowing On Unsafe Dividends For Monday's Breakfast

Mylan Shareholders Back Proposal to Buy Perrigo

Veeva Beats Q2 Earnings on Strong Revenues, Guides Up

Expect Perrigo To Grow, With Or Without Hostile Mylan

TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial

A Pivotal Moment For GlaxoSmithKline

Novartis' (NVS) Promacta Label Further Expanded in U.S.

Novartis to Buy Full Arzerra Rights from GlaxoSmithKline

Five Prime Therapeutics Announces Oral Presentation of Initial Data From Ongoing Phase 1b Trial of F

Five Prime Therapeutics Announces Oral Presentation of Initial Data From Ongoing Phase 1b Trial of FP-1039/GSK3052230 in Squamous Non Small Cell Lung Cancer and Mesothelioma at World Conference on Lung Cancer

See More GSK News...

GSK's Top Competitors

GSK $41.25 (0.10%)
Current stock: GSK
JNJ $95.17 (-1.09%)
Current stock: JNJ
NVS $98.35 (-0.29%)
Current stock: NVS
RHHBY $34.16 (-1.98%)
Current stock: RHHBY